Compare ONON & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONON | FMS |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | Switzerland | Germany |
| Employees | N/A | 108165 |
| Industry | Shoe Manufacturing | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.6B |
| IPO Year | 2021 | N/A |
| Metric | ONON | FMS |
|---|---|---|
| Price | $37.40 | $21.66 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 20 | 2 |
| Target Price | ★ $60.15 | $30.00 |
| AVG Volume (30 Days) | ★ 5.7M | 727.1K |
| Earning Date | 05-12-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.58 | N/A |
| Revenue Next Year | $19.98 | $3.83 |
| P/E Ratio | $56.05 | ★ $15.62 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.41 | $20.02 |
| 52 Week High | $61.29 | $30.46 |
| Indicator | ONON | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | 45.08 |
| Support Level | $34.38 | $21.26 |
| Resistance Level | $37.89 | $23.89 |
| Average True Range (ATR) | 1.45 | 0.43 |
| MACD | 0.30 | -0.04 |
| Stochastic Oscillator | 96.68 | 58.01 |
Founded in Switzerland in 2010, sportswear firm On Holding generates 93% of its sales from athletic shoes. The brand is best known for its running shoes and its distinctive CloudTec soles. On also produces athletic apparel (6% of sales) and accessories (1%). The firm's merchandise is available in more than 80 countries and is sold through both wholesale (58% of sales) and company-owned channels (42%). In 2025, On generated 58% of its sales in North America, 25% in Europe, the Middle East, and Africa, and 17% in the Asia-Pacific region.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.